GVS
870976
Hangzhou CNCR-IT
300250
Shanghai Newtouch Software
688590
Ucap Cloud Information Technology Co.,Ltd
688228
Yangtze Optical Electronic
688143
CN Stock MarketDetailed Quotes
002793 Luoxin Pharmaceuticals Group Stock
- 3.64
- -0.05-1.36%
Market Closed Jan 24 15:00 CST
3.96BMarket Cap-5.68P/E (TTM)
3.70High3.61Low114.90KlotVolume3.69Open3.69Pre Close41.81MTurnover1.06%Turnover RatioLossP/E (Static)1.09BShares5.8052wk High1.88P/B3.95BFloat Cap3.2252wk Low4.06Limit Up1.09BShs Float27.94Historical High3.32Limit Down2.44%Amplitude3.22Historical Low--Dividend TTM3.64Avg Price73.31KlotAsk--Div YieldTTM100Lot Size39.91KlotBid
Luoxin Pharmaceuticals Group Stock News
Luoxin Pharmaceutical: 2024 Annual Results Forecast
Luoxin Pharmaceutical: Report for the third quarter of 2024
Luoxin Pharmaceutical: 2024 Semi-Annual Report
Luoxin Pharmaceutical: 2024 Semi-Annual Report Summary
Luoxin Pharmaceuticals Group Stock: 2024 Interim Performance Forecast
Luoxin Pharmaceuticals Group Stock: 2023 Annual Report Summary
Luoxin Pharmaceuticals Group Stock: 2024 First Quarter Report
Luoxin Pharmaceuticals Group Stock: 2023 ANNUAL REPORT
Luoxin Pharmaceutical: 2023 Annual Results Forecast
Luoxin Pharmaceutical: Report for the third quarter of 2023
Luo Xin Pharmaceutical: Semi-Annual Report 2023
Luo Xin Pharmaceutical: Summary of the 2023 Semi-Annual Report
Roxin Pharmaceutical: 2023 semi-annual results forecast
Luoxin Pharmaceutical: 2022 Annual Report Summary
Luoxin Pharmaceutical: Report for the first quarter of 2023
Luo Xin Pharmaceutical: 2022 Annual Report
Luo Xin Pharmaceutical: 2022 Annual Performance Forecast
Luoxin Pharmaceutical: Report for the third quarter of 2022
Luo Xin Pharmaceutical: 2022 Semi-Annual Report
Luoxin Pharmaceutical: 2022 Semi-Annual Report Summary